Zantac75 Trademark Details

Zantac75 was registered on Tuesday, December 17, 1996 and is currently owned by Johnson & Johnson under the registration number 2022950 . This mark is dead with a status of Cancelled - Section 8. The last case file activity for this mark occured 16 years ago on Saturday, September 22, 2007, according to the United State Patent & Trademark Office
Word Mark Zantac75
Status Dead Registered 710 — Cancelled - Section 8

Current Owner

Johnson & Johnson of New Brunswick, NJ

View all trademarks for Johnson & Johnson
Other Trademarks for Johnson & Johnson

Previous Owners

Warner-Lambert Company of New York, NY

View all trademarks for Warner-Lambert Company
Other Trademarks for Warner-Lambert Company

Glaxo Group Limited

View all trademarks for Glaxo Group Limited
Serial Number 74647652
Registration Number 2022950
Status Date Saturday, September 22, 2007
Filing Date Saturday, September 22, 2007
Registration Date Tuesday, December 17, 1996
Attorney Mary-Ellen M. Devlin

Correspondent

Mary-Ellen M. Devlin
Boehringer Ingelheim USA Corporation
900 Ridgebury Road
Ridgefield CT 06877

Case File Statements

Goods & Services Pharmaceutical Preparations and Substances for the Treatment of Gastrointestinal Disorders

Classifications

International Class Codes
005 — Class 5 includes mainly pharmaceuticals and other preparations for medical or veterinary purposes.
U.S. Class Codes 006, 018, 044, 046, 051, 052
Status 2 — Sec. 8 – Entire Registration
Status Date Saturday, September 22, 2007
Primary Code 005

You must be signed in to print.

Once signed in, look for the PDF button.